These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12761949)

  • 21. Concurrent chemo-radiotherapy for nasopharyngeal carcinoma.
    Okita J; Hatta C; Terada T; Saeki N; Ogasawara H; Kakibuchi M; Kamikonya N; Sakagami M
    Auris Nasus Larynx; 2004 Mar; 31(1):43-7. PubMed ID: 15041053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment results of alternating chemoradiotherapy for nasopharyngeal cancer using cisplatin and 5-fluorouracil--a phase II study.
    Fuwa N; Shikama N; Hayashi N; Matsuzuka T; Toita T; Yuta A; Oonishi H; Kodaira T; Tachibana H; Nakamura T; Daimon T
    Oral Oncol; 2007 Oct; 43(9):948-55. PubMed ID: 17257880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase I/II study of neoadjuvant chemotherapy followed by radiation with boost chemotherapy for advanced T-stage nasopharyngeal carcinoma.
    Johnson FM; Garden AS; Palmer JL; Shin DM; Morrison W; Papadimitrakopoulou V; Khuri F; Clayman G; Goepfert H; Ang KK; Hong WK; Glisson BS
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):717-24. PubMed ID: 16199307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Radiotherapy alone versus neo-adjuvant chemotherapy and irradiation in the treatment of carcinoma of the cavum].
    Rodríguez Gutiérrez A; Calvo Boizas E; Soria Carreras P; Rodríguez Garrido JR; Rodríguez Sánchez CA; González G; Solbes Solbes R; Soler Ripoll JJ
    Acta Otorrinolaringol Esp; 1998 Oct; 49(7):548-53. PubMed ID: 9866221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5-fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma.
    Chua DT; Sham JS; Au GK
    Head Neck; 2004 Feb; 26(2):118-26. PubMed ID: 14762880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment results of continuous intra-arterial CBDCA infusion chemotherapy in combination with radiation therapy for locally advanced tongue cancer.
    Fuwa N; Kodaira T; Furutani K; Tachibana H; Nakamura T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jun; 105(6):714-9. PubMed ID: 18439857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperfractionated radiotherapy in locally advanced nasopharyngeal cancer. An analysis of 43 consecutive patients.
    Jereczek-Fossa BA; Morra A; DeBraud F; Alterio D; Mazzetta C; Rocca A; Catalano G; Bianchi L; Pasetti M; Chiesa F; Bruschini R; Orecchia R
    Strahlenther Onkol; 2004 Jul; 180(7):425-33. PubMed ID: 15241530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concurrent chemoradiotherapy in patients with nasopharyngeal cancer: prognostic significance of low expression of bax.
    Kang SY; Oh YT; Han JH; Choi JH; Lim HY; Kim HI; Lee HW; Jang JH; Park JS; Kim HC; Kang S; Chun M; Kim CH; Joo HJ
    Neoplasma; 2006; 53(5):450-6. PubMed ID: 17013542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.
    Ozyar E; Gurkaynak M; Yildiz F; Atahan IL
    Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experience in fractionated stereotactic body radiation therapy boost for newly diagnosed nasopharyngeal carcinoma.
    Chen HH; Tsai ST; Wang MS; Wu YH; Hsueh WT; Yang MW; Yeh IC; Lin JC
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1408-14. PubMed ID: 17126207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation therapy with UFT and low dose weekly cisplatin for nasopharyngeal carcinoma.
    Park JH; Nam SY; Lee SW; Kim SB; Kim SY; Lee BJ; Cho KJ; Kim JH; Ahn SD; Shin SS; Choi SH; Ahn JH; Choi EK
    Auris Nasus Larynx; 2005 Mar; 32(1):43-8. PubMed ID: 15882825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction chemotherapy with cisplatin, epirubicin, and paclitaxel (CEP), followed by concomitant radiotherapy and weekly paclitaxel for the management of locally advanced nasopharyngeal carcinoma. A Hellenic Cooperative Oncology Group phase II study.
    Fountzilas G; Tolis C; Kalogera-Fountzila A; Karanikiotis C; Bai M; Misailidou D; Samantas E; Athanassiou E; Papamichael D; Tsekeris P; Catodritis N; Nicolaou A; Plataniotis G; Makatsoris T; Papakostas P; Zamboglou N; Daniilidis J
    Strahlenther Onkol; 2005 Apr; 181(4):223-30. PubMed ID: 15827691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Superselective intra-arterial infusion chemotherapy for stage III/IV squamous cell carcinomas of the oral cavity: midterm results.
    Ikushima I; Korogi Y; Ishii A; Hirai T; Yamura M; Nishimura R; Baba Y; Yamashita Y; Shinohara M
    Eur J Radiol; 2008 Apr; 66(1):7-12. PubMed ID: 17604932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-dose-rate brachytherapy as part of a multidisciplinary treatment of nasopharyngeal lymphoepithelioma in childhood.
    Nakamura RA; Novaes PE; Antoneli CB; Fogaroli RC; Pellizzon AC; Ferrigno R; Maia MA; Salvajoli JV; Pereira AJ; Nishimoto IN
    Cancer; 2005 Aug; 104(3):525-31. PubMed ID: 15986481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Another way to estimate outcome of advanced nasopharyngeal carcinoma--is concurrent chemoradiotherapy adequate?
    Lin JC; Liang WM; Jan JS; Jiang RS; Lin AC
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):156-64. PubMed ID: 15337551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of preoperative radiochemotherapy on postoperative course and survival in patients with locally advanced squamous cell oesophageal carcinoma.
    Mariette C; Piessen G; Lamblin A; Mirabel X; Adenis A; Triboulet JP
    Br J Surg; 2006 Sep; 93(9):1077-83. PubMed ID: 16779882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Late complications of radiotherapy for nasopharyngeal carcinoma.
    Sumitsawan Y; Chaiyasate S; Chitapanarux I; Anansuthiwara M; Roongrotwattanasiri K; Vaseenon V; Tooncam H
    Auris Nasus Larynx; 2009 Apr; 36(2):205-9. PubMed ID: 18635325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemotherapy in locoregionally advanced nasopharyngeal carcinoma-a review.
    Krstevska V; Stojkovski I
    J BUON; 2008; 13(4):495-503. PubMed ID: 19145670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Quality of life of 192 disease-freely survival nasopharyngeal carcinoma patients after radiotherapy].
    Wu Y; Hu WH; Xia YF; Ma J; Liu MZ; Cui NJ
    Ai Zheng; 2005 Nov; 24(11):1376-83. PubMed ID: 16552967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.